Combined time‐restricted feeding and resistance training enhance tirzepatide‐induced improvements in adiposity and whole‐body insulin sensitivity in female mice
Authors:
- 30 October 2026
- journal article
- research article
- Published by Wiley in The Journal of Physiology
Abstract
Tirzepatide is a dual agonist of glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) receptors with potent effects on body weight regulation, glucose homeostasis and metabolic health. However, its interaction with dietary and exercise interventions as well as its impact on obesity and hepatic metabolic pathways, particularly in females, remain unclear. Here, we tested whether tirzepatide, alone or combined with time‐restricted feeding (TRF) or resistance training, modulates energy balance, strength performance, adipose tissue remodelling, insulin sensitivity and hepatic lipid accumulation in female mice. Female Swiss mice after 10 weeks of obesity induction were treated with tirzepatide, TRF or resistance training for 8 weeks. Tirzepatide was administered subcutaneously using a dose‐escalation protocol. TRF consisted of a 12 h feeding window, and resistance training was performed as stair climbing on alternating days. Body weight, caloric intake and feed efficiency were monitored longitudinally. Glucose homeostasis was assessed by intraperitoneal glucose and insulin tolerance tests. Adipose depots, skeletal muscle and liver mass were quantified, and hepatic lipid accumulation was evaluated by histology and RT‐qPCR of lipogenic metabolism genes. Tirzepatide reduced body weight gain and feed efficiency, consistent with a negative energy balance. When combined with TRF and resistance training, tirzepatide accelerated weight loss, and the addition of resistance training further enhanced this effect, bringing body weight close to control levels. These effects were associated with reduced adipose mass and adipocyte hypertrophy, indicating improved adipose tissue remodelling. Resistance training improved strength performance and increased skeletal muscle mass. Tirzepatide combined with TRF, with or without resistance training, improved glucose tolerance in female mice. All interventions reduced hepatic lipid accumulation. Collectively, tirzepatide, particularly in combination with TRF and resistance training, exerts enhanced metabolic benefits on obesity, insulin sensitivity and metabolic regulation in female mice. image Key points: Tirzepatide combined with time‐restricted feeding and resistance training produced greater reductions in body weight and adiposity in obese female mice. Combined interventions improved whole‐body insulin sensitivity more effectively than isolated strategies. Resistance training preserved skeletal muscle mass during tirzepatide‐induced weight loss. All interventions similarly reduced hepatic lipid accumulation and lipogenic gene expression. Tirzepatide‐based therapies enhanced systemic metabolic health without additional hepatic benefits from combined interventions.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/15679‐2)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/16630‐8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#309268/2023‐0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#441725/2023‐6)
This publication has 64 references indexed in Scilit:
- Insights into the Mechanism of Action of Tirzepatide: A Narrative ReviewDiabetes Therapy, 2025
- A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure–Response Relationship during Treatment of Obesity with TirzepatideClinical Pharmacology & Therapeutics, 2025
- Are Lean Body Mass and Fat-Free Mass the Same or Different Body Components? A Critical PerspectiveAdvances in Nutrition, 2024
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With ObesityJAMA, 2024
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without DiabetesJAMA, 2022
- Time-Restricted Eating, Intermittent Fasting, and Fasting-Mimicking Diets in Weight LossCurrent Obesity Reports, 2021
- Sex differences in metabolic regulation and diabetes susceptibilityDiabetologia, 2019
- Diet-induced obesity causes hypothalamic neurochemistry alterations in Swiss miceMetabolic Brain Disease, 2019
- Metabolic Alterations in Experimental Autoimmune Encephalomyelitis in Mice: Effects of Prior Physical ExerciseNeurophysiology, 2016
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005